Foley Hoag LLP advised Alloy Therapeutics on the deal. Alloy Therapeutics, a biotechnology ecosystem company, announced a $42 million Series D financing round led by its existing...
Alloy Therapeutics’ $42 Million Series D Financing Round
Alloy Therapeutics’ Acquisition of deepCDR Biologics
Walder Wyss acted as Swiss legal counsel for Alloy Therapeutics Inc on the deal. Vischer advised deepCDR Biologics AG. Alloy Therapeutics, a biotechnology ecosystem company, acquired...
Alloy Therapeutics’ $75M Series C Financing
Foley Hoag LLP advised Alloy Therapeutics on the deal. Alloy Therapeutics announced a $75 million Series C Financing. Proceeds from the Series C financing will support the...